Skip to main content
Advertisement
Advertisement
GKOS
GKOS logo
Glaukos Corporation
181.43
USD
Sponsored
+0.26
+0.14%
Oct 28, 16:00 UTC -4
Closed
exchange

After-Market

213.00

+31.57
+17.40%

Glaukos Corporation (GKOS) Earnings

GKOS Earnings Reports

Positive Surprise Ratio

GKOS beat 31 of 44 last estimates.

70%

Next Report

Date of Next Report
--
Estimate for Q-- -- (Revenue/ EPS)
--
/
--
Implied change from Q3 26 (Revenue/ EPS)
--
/
--
Implied change from Q-- -- (Revenue/ EPS)
--
/
--

Glaukos Corporation earnings per share and revenue

On Oct 28, 2026, GKOS reported earnings of 0.47 USD per share (EPS) for Q3 26, beating the estimate of -0.09 USD, resulting in a 611.98% surprise. Revenue reached 211.03 million, compared to an expected 171.41 million, with a 23.11% difference.
Looking ahead to -- --, -- analysts forecast an EPS of -- USD, with revenue projected to reach -- USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
Intuitive Surgical Inc.
Report Date
Oct 20, 2026 For Q3 26
Estimate
$2.69
Actual
$3.00
Surprise
+11.29%
logo
IQVIA Holdings Inc.
Report Date
Oct 27, 2026 For Q3 26
Estimate
$3.30
Actual
$3.34
Surprise
+0.97%
logo
Thermo Fisher Scientific, Inc.
Report Date
Oct 21, 2026 For Q3 26
Estimate
$6.46
Actual
$6.68
Surprise
+3.29%
logo
Axogen, Inc. Common Stock
Report Date
Oct 28, 2026 For Q3 26
Estimate
$0.14
Actual
$0.21
Surprise
+47.06%
logo
Integra LifeSciences Holdings
Report Date
Oct 21, 2026 For Q3 26
Estimate
$0.57
Actual
$0.59
Surprise
+3.04%
logo
Beta Bionics, Inc. Common Stock
Report Date
Oct 27, 2026 For Q3 26
Estimate
-$0.53
Actual
-$0.52
Surprise
+2.73%
logo
OrthoPediatrics Corp. Common Stock
Report Date
Oct 27, 2026 For Q3 26
Estimate
-$0.21
Actual
-$0.23
Surprise
-4.88%
logo
ClearPoint Neuro, Inc. Common Stock
Report Date
Oct 28, 2026 For Q3 26
Estimate
-$0.32
Actual
-$0.24
Surprise
+25.30%
FAQ
For Q3 2026, Glaukos Corporation reported EPS of $0.47, beating estimates by 611.98%, and revenue of $211.03M, 23.11% above expectations.
The stock price moved -- --, changed from -- before the earnings release to -- the day after.
The next earning report is scheduled for --.
Based on -- analysts, Glaukos Corporation is expected to report EPS of -- and revenue of -- for Q-- --.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement